Fibrosis: Clinical Trials

292 trials for Fibrosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

175 completed, 50 unknown, 26 recruiting, 19 terminated. 292 Phase 1, 117 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 1292Completed 175, Unknown 50, Recruiting 26, Terminated 19, Withdrawn 9, Not yet recruiting 8, Active not recruiting 3, Enrolling by invitation 1, Suspended 1
Phase 2117Completed 59, Unknown 26, Recruiting 11, Terminated 9, Withdrawn 5, Not yet recruiting 4, Active not recruiting 2, Suspended 1

Follow Fibrosis: new trials by email Literature Review of Fibrosis trials Research Report on Fibrosis

Trials (filtered) newest first · largest first

All 292 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Reversing InGuinal Hernia Trial: The Evaluation of Sex Hormones to Reverse Inguinal Hernias in Males
Fulvestrant, Anastrozole (ARIMIDEX™) - Inguinal Hernia Unilateral, Inguinal Hernia Bilateral
Phase 1RecruitingNorthwestern University302026-10-022026-10-06
Umbilical Cord Mesenchymal Stem Cell Therapy for Biliary Atresia
Umbilical Cord-Mesenchymal Stem Cells (UC-MSC), Kasai Portoenterostomy - Biliary Atresia, Kasai Operation
Phase 1RecruitingDr Cipto Mangunkusumo General Hospital402026-09-012026-09-09
Phase I/II Trial of Human Umbilical Cord Mesenchymal Stromal Cells for UDCA-Refractory Primary Biliary Cholangitis
Standard background therapy, Placebo, hUC-MSC Dose Level 1 - Primary Biliary Cholangitis
Phase 1 / Phase 2Not yet recruitingBeijing 302 Hospital682026-08-312026-08-31
FAPI PET Imaging - An Exploratory Study
[18F]FAPI-74 PET/CT - Thyroid Pathology, Head and Neck Cancer (H&N)
Phase 1 / Phase 2Not yet recruitingMartin Huellner7702026-08-012026-07-15
Dose-Escalation Study of Artesunate Patients With IPF
Artesuante, Placebo capsules - Idiopathic Pulmonary Fibrosis
Phase 1RecruitingJoseph C. Wu152026-08-012026-08-11
A Clinical Study on the Safety and Efficacy of Wide-Band Ultrasound Combined With Traditional Chinese Medicine Preparations in the Prevention and Treatment of Keloids
Wide-Band Ultrasound, traditional Chinese medicine - Keloid
Phase 1 / Phase 2Not yet recruitingFujian Medical University Union Hospital1202026-08-012026-07-01
Scar Remodeling After Burn Injury Using Allogeneic Adipose-derived Stromal Cells
Allogeneic adipose-Derived Mesenchymal Stromal Cells, Cryostor CS10 + Ringers Lactate - Scar Conditions and Fibrosis of Skin, Scar Quality Assessment and Safety
Phase 1 / Phase 2RecruitingCopenhagen University Hospital, Rigshospitalet392026-04-162026-06-09
Study on the Drug Interactions of HRS-9813, Pirfenidone and Nintedanib in Healthy Subjects
HRS-9813 Capsule, Nintedanib Soft Capsules, Pirfenidone Tablets - Pulmonary Fibrosis
Phase 1CompletedGuangdong Hengrui Pharmaceutical Co., Ltd202026-04-042026-09-21
Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer
Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging - Advanced Hepatocellular Carcinoma, Cirrhosis
Phase 1 / Phase 2RecruitingDevalingam Mahalingam592026-03-302026-10-23
Study of Hydroxynidone Capsules in Patients With Hepatic Impairment and Matched Healthy Controls
Hydronidone capsules - Liver Fibrosis
Phase 1CompletedBeijing Continent Pharmaceutical Co, Ltd.302026-03-252026-08-13
Safety Evaluation of MSC-based Therapy for Liver Cihcrosis Treatment
Umbilical cord mesenchymal stem cell-derived extracellular vesicles - Liver Cirrhosis
Phase 1Not yet recruitingVinmec Research Institute of Stem Cell and Gene Technology122026-03-152026-03-16
QTc Assessment in a Single-Dose Study of Hydronidone Capsules
Hydronidone, Placebo - Hepatic Fibrosis
Phase 1CompletedBeijing Continent Pharmaceutical Co, Ltd.482025-12-302026-08-13
The Phase Ⅰd Clinical Trial of Hydronidone Capsules
Hydronidone capsules, Placebo capsules - Liver Fibrosis
Phase 1CompletedBeijing Continent Pharmaceutical Co, Ltd.1382025-12-242026-09-21
Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases
Injection of 68Ga-NI-FAPI - Tumor, Cardiovascular Diseases
Phase 1 / Phase 2RecruitingPeking Union Medical College Hospital302025-12-172026-03-11
Bioequivalence and Adhesion of a Rotigotine Patch in Healthy Subjects
Rotigotine Transdermal Delivery System (TDS) - Bioequivalence, Adhesion
Phase 1CompletedAmarin Technologies S.A.U.352025-12-042026-08-19
Nucleoside Therapy in Patients With Telomere Biology Disorders
deoxycytidine, deoxythymidine - Telomere Biology Disorders, Dyskeratosis Congenita
Phase 1RecruitingSuneet Agarwal362025-09-292026-08-04
Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease
Saroglitazar Magnesium 1 mg - Cholestatic Liver Disease
Phase 1RecruitingZydus Therapeutics Inc.62025-08-052026-09-14
The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial
Commensal Bacteria Strains - Liver Diseases, Liver Failure
Phase 1RecruitingUniversity of Chicago242025-08-042025-11-04
Clinical Outcomes of Early Kasai Surgery With Umbilical Cord MSCs in Biliary Atresia
Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs), Kasai Portoenterostomy - Biliary Atresia, Kasai Portoenterostomy
Phase 1Not yet recruitingUniversitas Diponegoro142025-06-172025-06-08
CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection
Ex Vivo CRISPR-Cas9 Gene Editing of Donor Liver - Liver Diseases, Liver Cancer
Phase 1 / Phase 2RecruitingAMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC902025-06-012025-07-08

Showing 20 of 292. Sign in to see all of them.

Narrower conditions

Liver Cirrhosis (93)  ·  Cicatrix (43)  ·  Pulmonary Fibrosis (34)  ·  Liver Cirrhosis, Biliary (26)  ·  Keloid (19)  ·  Non-alcoholic Fatty Liver Disease (15)  ·  Idiopathic Pulmonary Fibrosis (14)  ·  Liver Diseases (12)  ·  Carcinoma, Hepatocellular (10)  ·  Tissue Adhesions (10)  ·  Cicatrix, Hypertrophic (8)  ·  Fatty Liver (8)  ·  Hepatitis C (8)  ·  End Stage Liver Disease (7)

Broader conditions

Pathological Conditions, Signs and Symptoms (292)  ·  Pathologic Processes (291)  ·  Digestive System Diseases (159)  ·  Liver Diseases (140)  ·  Respiratory Tract Diseases (36)  ·  Lung Diseases, Interstitial (34)  ·  Lung Diseases (32)  ·  Bile Duct Diseases (30)  ·  Biliary Tract Diseases (30)  ·  Skin and Connective Tissue Diseases (29)  ·  Cicatrix (28)  ·  Cholestasis, Intrahepatic (26)  ·  Liver Cirrhosis (26)  ·  Cholestasis (24)

Interventions

TGFB3 protein, human (9)  ·  NRL972 (5)  ·  Ursodeoxycholic Acid (5)  ·  ICG 001 (4)  ·  Magnetic Resonance Spectroscopy (4)  ·  Rituximab (4)  ·  Saline Solution (4)  ·  Fecal Microbiota Transplantation (3)  ·  Sodium Chloride (3)  ·  Triamcinolone Acetonide (3)  ·  hydronidone (3)  ·  pirfenidone (3)  ·  68Ga-FAPI (2)  ·  Cell- and Tissue-Based Therapy (2)  ·  Congresses as Topic (2)

Sponsors

Renovo (11)  ·  AstraZeneca (6)  ·  Bristol-Myers Squibb (6)  ·  GlaxoSmithKline (5)  ·  Norgine (5)  ·  Beijing 302 Hospital (4)  ·  Mayo Clinic (4)  ·  National Cancer Institute (NCI) (4)  ·  Peking Union Medical College Hospital (4)  ·  Air Force Military Medical University, China (3)  ·  Baermed (3)  ·  Beijing Continent Pharmaceutical Co, Ltd. (3)  ·  Cascade Pharmaceuticals, Inc (3)  ·  Galecto Biotech AB (3)  ·  Kiminori Kimura, MD (3)

Countries

United States (112)  ·  China (47)  ·  United Kingdom (26)  ·  Germany (9)  ·  Australia (8)  ·  Canada (7)  ·  Italy (7)  ·  Japan (7)  ·  Spain (6)  ·  Indonesia (5)  ·  Iran (5)  ·  South Korea (5)  ·  Belgium (4)  ·  Brazil (4)  ·  Bulgaria (4)

Top investigators

Jonathan Duncan (4)  ·  Kiminori Kimura, MD (4)  ·  Daiming Fan (3)  ·  Michael J Davies (3)  ·  Zahariy Krastev, MD (3)  ·  Hamid Gourabi, PhD (2)  ·  Hossein Baharvand, PhD (2)  ·  Jared Jagdeo, MD, MS (2)  ·  Jasmohan S Bajaj, MD (2)  ·  Jasmohan S Bajaj, MD, MSc (2)

Results publications

PMID 19362676, PMID 10102814, PMID 10415784, PMID 10655252, PMID 12563677, PMID 14719037, PMID 15663512, PMID 17181919, PMID 17694216, PMID 17903050, PMID 18068515, PMID 18097874, PMID 18346996, PMID 18459515, PMID 18668653, PMID 19146602, PMID 19397687, PMID 19453649, PMID 19998041, PMID 21131395, PMID 21194255, PMID 21233083, PMID 21751289, PMID 21810549, PMID 22028728, PMID 22282526, PMID 22545014, PMID 22731679, PMID 23077622, PMID 23220074, PMID 23453404, PMID 23565181, PMID 23590233, PMID 24074360, PMID 24561556, PMID 24835895, PMID 24876849, PMID 25329189, PMID 25485805, PMID 25667206, PMID 25906706, PMID 26006200, PMID 26143343, PMID 26336510, PMID 26867177, PMID 26869678, PMID 26972567, PMID 27148676, PMID 27192671, PMID 27484782

NIH funding

2016 (2), 2018 (2), P30CA060553 (2), 2009 (1), 2014 (1), I01CX002516 (1), M01RR000051 (1), N01CN00035 (1), N01CN00042 (1), P01CA108671 (1), P30CA015083 (1), P30CA016672 (1), P30DK034989 (1), R01AA029398 (1), R01CA263776 (1)